How to make regenerative medicine happen
Cell therapies hold the promise of more effective treatments for a range of diseases, but they face a long and expensive route to market. The key is to reduce risk and attract investors, says Keith Thompson, head of the UK Cell Therapy Catapult
Back small companies to deliver new medicines
Pharmaceutical R&D functions at its best in small, agile and innovative SMEs. Replacing state subsidies and grant funding for research with start-up and development capital, would bring productivity improvements, says Mark Bloomfield, CEO of French biotech Polyplus Transfection
Sarah Springman to become Rector of ETH Zurich
The ETH Board confirmed today that Sarah Springman, Professor of Geotechnical Engineering, is to become the new Rector of ETH Zurich. Alongside Lino Guzzella, who will move from the office of Rector to the Presidency, Springman will help shape the future of ETH Zurich as part of the Executive Board from January 2015.
Science|Business Innovation Board AISBL Annual Report 2012-2013
Could it help European universities innovate?
Perceptions of ACES finalists about the process of science entrepreneurship